Inactivated influenza vaccine, high-dose
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Inactivated influenza vaccine, high-dose, covering 2016-08-16 to 2025-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older [Phase 1, Phase 2]